← Back to all trials
Recruiting
NCT07285460
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Conditions: Hemophilia
Sex: Male
Ages: 1 Year – 11 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 85
Sponsor: Sanofi
Location: The Luskin Orthopaedic Institute for Children- Site Number : 8400013 Los Angeles California
Summary
This is a parallel, Phase 3, two-arm, open-label study to evaluate the efficacy and safety of treatment with fitusiran prophylaxis administered to male pediatric participants (aged 1 to \
Eligibility Criteria
Inclusion Criteria:
Participants not previously exposed to fitusiran are eligible to be included in the study only if all of the following criteria apply:
* Participant must be 1 to \
Source: ClinicalTrials.gov (NCT07285460). StuddyBuddy aggregates publicly available trial information.
